15 Additional Drugs Chosen For Medicare Negotiation
The Centers for Medicare and Medicaid Services (CMS) has picked 15 more drugs for Medicare price negotiation.
The Centers for Medicare and Medicaid Services (CMS) has picked 15 more drugs for Medicare price negotiation.
The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of weight loss drugs such as Ozempic, a new study has found.
By Rick Amato November 14, 2024 (Views expressed by guest commentators may not reflect the views of OAN or its affiliates.)
During a Senate committee hearing on Tuesday, lawmakers questioned the manufacturer of popular weight loss drugs like Ozempic and Wegovy, citing what Senator Bernie Sanders called “outrageously high” drug prices.
Eli Lilly said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies.
A new class of weight loss drugs is transforming the U.S. healthcare system in ways that could extend to equally hard-to-treat areas.